XTL Biopharmaceuticals Ltd. (XTLB)
Nasdaq: XTLB · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2004
Who runs XTL Biopharmaceuticals Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
0
of 1 people with a filing in the last fifteen months
Directors reporting now
1
1 people on the record since 2026
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hillel Fain Osnat | director | Mar 2026 | Mar 23, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Segal Niv | other | Mar 2026 | Mar 23, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.